As the "black-box" problem creates challenges for AI, explainable AI can help reshape business-to-business operations by ...

On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

The proposed legislation, sponsored by Rep. David Schweikert (R-Ariz.), would amend the Federal Food, Drug, and Cosmetic Act ...

On one side, Ripple’s XRP ETF continues its years-long quest for regulatory clarity, with growing anticipation around a potential spot ETF approval. On the other, IntelMarkets (INTL), an AI-powered ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

The new portable ultrasound systems have AI algorithms that help to decode ... According to the U.S. Food and Drug Administration (FDA), more than 50 FDA-approved AI-driven ultrasound systems ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

was approved by Nvidia in December 2024, the report added. These chips would be used for Nvidia's less powerful AI processors customized for the Chinese market, according to the report.

TL;DR: Samsung has received approval to supply NVIDIA with its 8-layer HBM3E memory chips for less powerful AI GPUs in China, despite previous distrust from NVIDIA's CEO. SK hynix remains NVIDIA's ...

with a focus on AI collaboration. On January 28, it was announced that GE HealthCare (NASDAQ:GEHC) received FDA 510(k) clearance for its updated Voluson Expert Series ultrasound systems ...